# M7.7E-B readiness reassessment

## Evidence gained

The dedicated QA organization safely supports authenticated DEV mutations without using operational DEV records. Product publication, order creation, quantitative fulfillment, manual shipment metadata, manual payment, and immutable refund behavior were demonstrated. Three concrete defects were corrected and deployed only to `dev`.

## Remaining blockers and findings

| Classification | Item | Why it remains |
| --- | --- | --- |
| P1 | Full authenticated workflow matrix | Flatbed, Roll, Proofing, Prepress, Inbound, Portal, full AI command/GO, and cross-workflow close/reopen are not yet executed against QA fixtures. |
| P1 | Isolated `TEST_DATABASE_URL` | QA validation does not replace database-backed automated test isolation. Existing Jest paths remain guarded because the configured test database fails the safety marker check. |
| P1 | Provider test validation | The QA tenant intentionally has zero integrations. Stripe TEST, Gmail inbound read, QuickBooks sandbox, and carrier APIs were neither configured nor called. |
| External M8 action | Production cutover controls | DEV QA evidence does not authorize PROD reconciliation, deployment, or provider writes. |

## Disposition

**M7.7E-B remains IN PROGRESS / NOT READY FOR CUTOVER.** The completed evidence removes the observed product and shipment-idempotency defects, but it does not substitute for the unexecuted operational and provider-safe parts of the matrix.
